Back to Journals » Drug Design, Development and Therapy » Volume 14

Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19

Total article views   Abstract views HTML views PDF downloads Totals
4,645 Dovepress* 3,714 416+ 1,114 4,130
PubMed Central* 0 515 128 515
Totals 3,714 931 1,242 4,645
*Since 6 July 2020
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar